ask="N/A"
ask_size="N/A"
average_daily_volume="218916"
bid="N/A"
bid_size="N/A"
book_value="0.56"
change="N/A"
change_from_200_day_moving_average="0.80"
change_from_50_day_moving_average="0.46"
change_from_52_week_high="-0.60"
change_From_52_week_low="1.21"
change_in_percent="N/A"
close="3.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="N/A"
high_52_weeks="3.87"
last_trade_date="2/13/2017"
last_trade_price="3.27"
last_trade_size="N/A"
last_trade_time="3:59pm"
low="N/A"
low_52_weeks="2.06"
market_capitalization="61.11M"
moving_average_200_day="2.47"
moving_average_50_day="2.81"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.55%"
percent_change_from_50_day_moving_average="+16.43%"
percent_change_from_52_week_high="-15.50%"
percent_change_from_52_week_low="+58.73%"
previous_close="3.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.81"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="0"
weeks_range_52="2.06 - 3.87"
